GB1101366A - Pharmaceutical compositions and a process for the manufacture thereof - Google Patents

Pharmaceutical compositions and a process for the manufacture thereof

Info

Publication number
GB1101366A
GB1101366A GB37310/66A GB3731066A GB1101366A GB 1101366 A GB1101366 A GB 1101366A GB 37310/66 A GB37310/66 A GB 37310/66A GB 3731066 A GB3731066 A GB 3731066A GB 1101366 A GB1101366 A GB 1101366A
Authority
GB
United Kingdom
Prior art keywords
benzodiazepin
exchange resin
groups
acidic ion
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB37310/66A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1101366A publication Critical patent/GB1101366A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heat-Exchange Devices With Radiators And Conduit Assemblies (AREA)

Abstract

A pharmaceutical composition comprises 7-nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one adsorbed on an acidic ion-exchange resin, e.g. a copolymer of styrene and 8% by wt. of divinyl benzene which is either sulphonated or carboxylated, or a polysaccharide (dextran) cross-linked wither with sulphoethyl groups orcarboxymethyl groups. The composition may be made by treating a solution of the above benzodiazepin-2-one compound in methylene chloride with the acidic ion-exchange resin and subsequently distilling off the solvent. The composition may also contain water, carboxymethyl cellulose, sodium benzoate, sodium saccharin, sodium citrate, sugar, and citric acid.
GB37310/66A 1965-08-20 1966-08-19 Pharmaceutical compositions and a process for the manufacture thereof Expired GB1101366A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1177965 1965-08-20

Publications (1)

Publication Number Publication Date
GB1101366A true GB1101366A (en) 1968-01-31

Family

ID=4376790

Family Applications (1)

Application Number Title Priority Date Filing Date
GB37310/66A Expired GB1101366A (en) 1965-08-20 1966-08-19 Pharmaceutical compositions and a process for the manufacture thereof

Country Status (14)

Country Link
JP (1) JPS507079B1 (en)
BE (1) BE685589A (en)
DE (1) DE1617513C3 (en)
DK (1) DK111277B (en)
ES (1) ES330391A1 (en)
FI (1) FI45726C (en)
FR (1) FR6063M (en)
GB (1) GB1101366A (en)
IL (1) IL26306A (en)
IT (1) IT1053660B (en)
MY (1) MY6900059A (en)
NL (1) NL6610569A (en)
NO (1) NO120752B (en)
SE (1) SE351978B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175915A1 (en) * 2000-07-27 2002-01-30 Rohm And Haas Company A method for preparing resinates
EP1175914A2 (en) * 2000-07-27 2002-01-30 Rohm And Haas Company A resinate composition
EP1293209A1 (en) * 2001-09-17 2003-03-19 Rohm And Haas Company Oral pharmaceutical dosage forms with reduced potential for drug abuse
EP1467769B1 (en) * 2002-01-18 2008-05-28 Rohm and Haas Company Use of a resinate in the preparation of a formulation for smoking cessation

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175915A1 (en) * 2000-07-27 2002-01-30 Rohm And Haas Company A method for preparing resinates
EP1175914A2 (en) * 2000-07-27 2002-01-30 Rohm And Haas Company A resinate composition
EP1175914A3 (en) * 2000-07-27 2002-05-02 Rohm And Haas Company A resinate composition
KR100869486B1 (en) * 2000-07-27 2008-11-19 롬 앤드 하스 캄파니 A method for preparing resinates
EP1293209A1 (en) * 2001-09-17 2003-03-19 Rohm And Haas Company Oral pharmaceutical dosage forms with reduced potential for drug abuse
EP1467769B1 (en) * 2002-01-18 2008-05-28 Rohm and Haas Company Use of a resinate in the preparation of a formulation for smoking cessation
CN1615156B (en) * 2002-01-18 2012-05-30 罗门哈斯公司 Preparation of resinates

Also Published As

Publication number Publication date
FI45726C (en) 1972-09-11
FR6063M (en) 1968-05-27
DE1617513A1 (en) 1970-12-23
IL26306A (en) 1970-02-19
DE1617513B2 (en) 1973-08-16
JPS507079B1 (en) 1975-03-20
IT1053660B (en) 1981-10-10
FI45726B (en) 1972-05-31
NO120752B (en) 1970-11-30
MY6900059A (en) 1969-12-31
ES330391A1 (en) 1967-10-16
DE1617513C3 (en) 1974-04-18
SE351978B (en) 1972-12-18
DK111277B (en) 1968-07-15
NL6610569A (en) 1967-02-21
BE685589A (en) 1967-02-17

Similar Documents

Publication Publication Date Title
BE754111A (en) NEW 7ALPHA- AND 7BETA-METHYL-3ALPHA, 5ALPHA- CYCLOANDROSTANES AND SIMILAR 19-NOR COMPOUNDS AND THEIR PREPARATION PROCESS
IL35688A (en) Substituted n-allyl-2-arylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
BE757742A (en) PROCESS FOR THE PREPARATION OF AROMATIC COMPOUNDS
GB1101366A (en) Pharmaceutical compositions and a process for the manufacture thereof
BE756725A (en) PROCESS FOR THE PREPARATION OF 3,3,3-TRIFLUOROPROPYLMETHYLPOLYSILOXANES
FI51700C (en) Process for the preparation of 6-phenyl-4H-s-triazolo (1,5a) (1,4) -benzodiazepines useful as sedatives.
IL35847A0 (en) New evomonoside derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
NL143271B (en) PROCESS FOR THE PREPARATION OF FRAGRANCE COMPOSITIONS.
IL35689A0 (en) 2-arylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
IL34747A0 (en) Ergonorcornine,its 1-methyl derivative and their salts,their preparation and pharmaceutical compositions containing them
CA945473A (en) PROCESS FOR STABILIZATION OF A COMPOSITION OF 2.alpha.,3.alpha.-EPITHIO-ANDROSTANES AND COMPOSITION OBTAINED THEREBY
NL144592B (en) PROCESS FOR THE PREPARATION OF 3,4-DIHYDROXYPHENYLALANINE COMPOUNDS.
PH10103A (en) 1)aryl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin 2-ones derivatives,its pharmaceutical composition and process of preparation
IL33821A (en) 1,3-dihydro-5-phenyl or pyridyl-2h-1,4-benzodiazepin-2-onederivatives,their preparation and pharmaceutical compositions containing them
IL34404A (en) Insecticidal compositions containing 2-chloro-2-thiono-1,3,2-dioxaphosphorinane derivatives and certain new compounds of this type
CA937564A (en) OXO-3-METHYL-7.alpha.R-13.beta.X-17.alpha.YO-17.beta. GONA 4,9,11-TRIENES ET PROCEDE DE PREPARATION
IL34549A (en) Benzofuran derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IL34788A0 (en) 10,11-dihydrodibenzoazepine derivatives,process for their preparation and compositions containing them
BE748290A (en) PROCESS FOR THE PREPARATION OF DELTA 4,6- OR DELTA 5 (10), 6-3-OXO-19-STEROIDS
IL35232A (en) Anticonvulsive pharmaceutical compositions containing 3,3-dimethyl-1-phenyl-1-phthalane-acetamide
RO63744A2 (en) PROCEDURE FOR PREPARATION OF 1,3-DIACETOXY-2-METHYLENE-PROPANE
CA822642A (en) Pharmaceutical compositions containing 2,6-dichloro-benzene compounds
CA825217A (en) Stabilization of 1,1,1-trichloroethane
AU437447B2 (en) Process forthe preparation of 5 cyanopropyl) hydantoin
CA824164A (en) Aminoalkyl derivatives of 6,11-dihydro-dibenzo-b-e)-oxepine and -thiepine, process for their preparation and compositions thereof